ENPICOM B.V.



ENPICOM aims to become one of the global leaders in personalizing immunotherapy with groundbreaking bioinformatics methods and state-of-the-art software to accelerate drug development, and improve patient stratification & treatment monitoring of immunotherapies. Innovative repertoire sequencing data management, analysis, and visualization will empower biopharma companies and doctors to make the adaptive immune system our strongest weapon in the battle against deadly diseases.